Julie Bertrand

Has grant

University College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Evaluation of Model-Based BioEquivalence (MBBE) statistical approaches for sparse designs PK studies

Open Date: 2019-09-01

Close Date: 2021-09-01

Grant: Close

Evaluation of Model-Based BioEquivalence (MBBE) statistical approaches for sparse designs PK studies

Open Date: 2016-09-01

Close Date: 2019-03-01

Articles (15)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (8)

Aurélie Barrail-Tran

Université Paris-Saclay

FRANCE

View details

Greg Irving

Honorary Professor

University of Oxford

UNITED KINGDOM

View details

VICTORIA HARRIS

University of Oxford

UNITED KINGDOM

View details

Jérémie Guedj

Université Paris Cité

FRANCE

View details

Solène Desmée

Université de Tours

FRANCE

View details

Duncan Richards

University of Oxford

UNITED KINGDOM

View details

Paul Little

University of Southampton

UNITED KINGDOM

View details

Christopher Butler

University of Oxford

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Julie Bertrand

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (15)

A Viroimmunologic Model to Characterize the Antiviral Effect of Molnupiravir in Outpatients Infected With SARS-CoV-2: Implication for Treatment Duration

Levofloxacin in Bone and Joint Infections: Development of an Application for Model‐Informed Precision Dosing

Correction: Uncertainty Computation at Finite Distance in Nonlinear Mixed Effects Models—a New Method Based on Metropolis–Hastings Algorithm

Uncertainty Computation at Finite Distance in Nonlinear Mixed Effects Models—a New Method Based on Metropolis-Hastings Algorithm

Isatuximab–dexamethasone–pomalidomide combination effects on serum M protein and PFS in myeloma: Development of a joint model using phase I/II data

Guiding safer risperidone prescribing in Alzheimer's disease with therapeutic drug monitoring

Pharmacokinetic Model of Tenofovir and Emtricitabine and Their Intracellular Metabolites in Patients in the ANRS 134-COPHAR 3 Trial Using Dose Records

Assessing the Increased Variability in Individual Lesion Kinetics During Immunotherapy: Does It Exist, and Does It Matter?

Modelling the association between biomarkers and clinical outcome: An introduction to nonlinear joint models

Impact of study design and statistical model in pharmacogenetic studies with gene‐treatment interaction

Population Pharmacokinetic Model of Plasma and Cellular Mycophenolic Acid in Kidney Transplant Patients from the CIMTRE Study.

Towards safer risperidone prescribing in Alzheimer's disease.

New Model-Based Bioequivalence Statistical Approaches for Pharmacokinetic Studies with Sparse Sampling.

Bayesian inference using Hamiltonian Monte-Carlo algorithm for nonlinear joint modeling in the context of cancer immunotherapy.

Timing of Antiviral Treatment Initiation is Critical to Reduce SARS-CoV-2 Viral Load.

Collaborators (8)

Aurélie Barrail-Tran

Greg Irving

VICTORIA HARRIS

Jérémie Guedj

Solène Desmée

Duncan Richards

Paul Little

Christopher Butler

Make your next move.